M-209

Milnacipran-D10 hydrochloride solution

100 μg/mL in methanol (as free base), certified reference material, ampule of 1 mL, Cerilliant®

Manufacturer: Supelco

CAS Number: 1217774-40-7

Select a Size

Pack Size SKU Availability Price
1 ML M-209-1-ML In Stock ₹ 29,054.30

M-209 - 1 ML

₹ 29,054.30

In Stock

Quantity

1

Base Price: ₹ 29,054.30

GST (18%): ₹ 5,229.774

Total Price: ₹ 34,284.074

grade

certified reference material

Quality Level

300

form

liquid

feature

Snap-N-Spike®/Snap-N-Shoot®

packaging

ampule of 1 mL

manufacturer/tradename

Cerilliant®

concentration

100 μg/mL in methanol (as free base)

technique(s)

gas chromatography (GC): suitableliquid chromatography (LC): suitable

application(s)

clinical testing

format

single component solution

Other Options

Image Product Name Manufacturer Price Range
1217774-40-7 | rac-Milnacipran-d10 Hydrochloride
-- ₹ 22,673.40 - ₹ 1,09,089.00

Related Products

Img

Supelco

V-058

100 μg/mL (THF:Ethanol with 0.1% BH...

Img

Supelco

G-018

100 μg/mL in methanol, ampule of 1 ...

Img

Sigma Aldrich

RDEN1501

UKAS ISO/IEC17025 and ISO 17034 cer...

Img

Sigma Aldrich

RDEN2501

UKAS ISO/IEC17025 and ISO 17034 cer...

Img

Supelco

E-129

1 mg/mL in methanol (as free base),...

Img

Supelco

E-091

100 μg/mL in methanol (as free base...

Img

Supelco

E-130

100 μg/mL in methanol (as free base...

Img

Sigma Aldrich

PHL84767

phyproof® Reference Substance...

Description

  • General description: This Snap-N-Shoot® stable-labeled internal standard is suitable for quantitation of milnacipran levels in urine, serum, or plasma by LC/MS or GC/MS for urine drug testing, clinical toxicology, or forensic analysis. Milnacipran, sold under the brand names Savella, Ixel, Dalcipran, or Toledomin, is a serotonin-norepinephrine reuptake inhibitor (SNRI) used in the treatment of depression. In 2009, the US Food and Drug Administration (FDA) approved milnacipran for management of the chronic pain disorder fibromyalgia, making it only the third drug approved in the US for this indication besides duloxetine and pregabalin.
  • Legal Information: CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

SAFETY INFORMATION

Pictograms

GHS02,GHS06,GHS08

Signal Word

Danger

Hazard Statements

H225,H301 + H311 + H331,H370

Precautionary Statements

P210 - P260 - P280 - P301 + P310 + P330 - P308 + P311 - P370 + P378 - P403 + P233

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

WGK

WGK 2